Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 179

1.

Optimizing Blood Transfusion Practices Through Bundled Intervention Implementation in Patients With Gynecologic Cancer Undergoing Laparotomy.

Wallace SK, Halverson JW, Jankowski CJ, DeJong SR, Weaver AL, Weinhold MR, Borah BJ, Moriarty JP, Cliby WA, Kor DJ, Higgins AA, Otto HA, Dowdy SC, Bakkum-Gamez JN.

Obstet Gynecol. 2018 Apr 6. doi: 10.1097/AOG.0000000000002463. [Epub ahead of print]

PMID:
29630007
2.

Uterine serous carcinoma: Reassessing effectiveness of platinum-based adjuvant therapy.

Tortorella L, Langstraat CL, Weaver AL, McGree ME, Bakkum-Gamez JN, Dowdy SC, Cliby WA, Keeney GL, Sherman ME, Weroha SJ, Mariani A, Podratz KC.

Gynecol Oncol. 2018 Mar 14. pii: S0090-8258(18)30141-0. doi: 10.1016/j.ygyno.2018.02.022. [Epub ahead of print]

PMID:
29550183
3.

Adoption of Minimally Invasive Surgery and Decrease in Surgical Morbidity for Endometrial Cancer Treatment in the United States.

Casarin J, Multinu F, Ubl DS, Dowdy SC, Cliby WA, Glaser GE, Butler KA, Ghezzi F, Habermann EB, Mariani A.

Obstet Gynecol. 2018 Feb;131(2):304-311. doi: 10.1097/AOG.0000000000002428.

PMID:
29324598
4.

Investigation of factors affecting the efficacy of 3C23K, a human monoclonal antibody targeting MISIIR.

Gill SE, Zhang Q, Keeney GL, Cliby WA, Weroha SJ.

Oncotarget. 2017 Jul 27;8(49):85214-85223. doi: 10.18632/oncotarget.19620. eCollection 2017 Oct 17.

5.

Need of informatics in designing interoperable clinical registries.

Rastegar-Mojarad M, Sohn S, Wang L, Shen F, Bleeker TC, Cliby WA, Liu H.

Int J Med Inform. 2017 Dec;108:78-84. doi: 10.1016/j.ijmedinf.2017.10.004. Epub 2017 Oct 10.

PMID:
29132635
6.

Clinical significance of enlarged cardiophrenic lymph nodes in advanced ovarian cancer: Implications for survival.

Mert I, Kumar A, Sheedy SP, Weaver AL, McGree ME, Kim B, Cliby WA.

Gynecol Oncol. 2018 Jan;148(1):68-73. doi: 10.1016/j.ygyno.2017.10.024. Epub 2017 Nov 10.

PMID:
29129390
7.

Comparison of a sentinel lymph node mapping algorithm and comprehensive lymphadenectomy in the detection of stage IIIC endometrial carcinoma at higher risk for nodal disease.

Ducie JA, Eriksson AGZ, Ali N, McGree ME, Weaver AL, Bogani G, Cliby WA, Dowdy SC, Bakkum-Gamez JN, Soslow RA, Keeney GL, Abu-Rustum NR, Mariani A, Leitao MM Jr.

Gynecol Oncol. 2017 Dec;147(3):541-548. doi: 10.1016/j.ygyno.2017.09.030. Epub 2017 Sep 29.

PMID:
28965698
8.

Intraperitoneal disease dissemination patterns are associated with residual disease, extent of surgery, and molecular subtypes in advanced ovarian cancer.

Torres D, Kumar A, Wallace SK, Bakkum-Gamez JN, Konecny GE, Weaver AL, McGree ME, Goode EL, Cliby WA, Wang C.

Gynecol Oncol. 2017 Dec;147(3):503-508. doi: 10.1016/j.ygyno.2017.09.021. Epub 2017 Sep 28.

PMID:
28964622
9.

Concomitant venous thromboembolism at the time of primary EOC diagnosis: Perioperative outcomes and survival analyses.

Kumar A, Hurtt CC, Cliby WA, Martin JR, Weaver AL, McGree ME, Langstraat CL, Bakkum-Gamez JN.

Gynecol Oncol. 2017 Dec;147(3):514-520. doi: 10.1016/j.ygyno.2017.09.020. Epub 2017 Sep 22.

PMID:
28947173
10.

A matter of margins: Surgical and pathologic risk factors for recurrence in extramammary Paget's disease.

Long B, Schmitt AR, Weaver AL, McGree M, Bakkum-Gamez JN, Brewer J, Cliby WA.

Gynecol Oncol. 2017 Nov;147(2):358-363. doi: 10.1016/j.ygyno.2017.09.008. Epub 2017 Sep 19.

PMID:
28935274
11.

Functional not chronologic age: Frailty index predicts outcomes in advanced ovarian cancer.

Kumar A, Langstraat CL, DeJong SR, McGree ME, Bakkum-Gamez JN, Weaver AL, LeBrasseur NK, Cliby WA.

Gynecol Oncol. 2017 Oct;147(1):104-109. doi: 10.1016/j.ygyno.2017.07.126. Epub 2017 Jul 19.

PMID:
28734497
12.

Clinical Utility of Preoperative Computed Tomography in Patients With Endometrial Cancer.

Bogani G, Gostout BS, Dowdy SC, Multinu F, Casarin J, Cliby WA, Frigerio L, Kim B, Weaver AL, Glaser GE, Mariani A.

Int J Gynecol Cancer. 2017 Oct;27(8):1685-1693. doi: 10.1097/IGC.0000000000001076.

PMID:
28704325
13.

Inflammatory and Nutritional Serum Markers as Predictors of Peri-operative Morbidity and Survival in Ovarian Cancer.

Kumar A, Torres ML, Cliby WA, Kalli KR, Bogani G, Aletti G, Nitschmann CC, Multinu F, Weaver AL, Block MS, Mariani A.

Anticancer Res. 2017 Jul;37(7):3673-3677.

PMID:
28668859
14.

Vaginal vs. robotic hysterectomy for patients with endometrial cancer: A comparison of outcomes and cost of care.

Nitschmann CC, Multinu F, Bakkum-Gamez JN, Langstraat CL, Occhino JA, Weaver AL, Cliby WA, Mariani A, Dowdy SC.

Gynecol Oncol. 2017 Jun;145(3):555-561. doi: 10.1016/j.ygyno.2017.03.002. Epub 2017 Apr 6.

PMID:
28392125
15.

Factors Predicting Use of Neoadjuvant Chemotherapy Compared With Primary Debulking Surgery in Advanced Stage Ovarian Cancer-A National Cancer Database Study.

Leiserowitz GS, Lin JF, Tergas AI, Cliby WA, Bristow RE.

Int J Gynecol Cancer. 2017 May;27(4):675-683. doi: 10.1097/IGC.0000000000000967.

16.

Pooled Clustering of High-Grade Serous Ovarian Cancer Gene Expression Leads to Novel Consensus Subtypes Associated with Survival and Surgical Outcomes.

Wang C, Armasu SM, Kalli KR, Maurer MJ, Heinzen EP, Keeney GL, Cliby WA, Oberg AL, Kaufmann SH, Goode EL.

Clin Cancer Res. 2017 Aug 1;23(15):4077-4085. doi: 10.1158/1078-0432.CCR-17-0246. Epub 2017 Mar 9.

17.

A prospective algorithm to reduce anastomotic leaks after rectosigmoid resection for gynecologic malignancies.

Kalogera E, Nitschmann CC, Dowdy SC, Cliby WA, Langstraat CL.

Gynecol Oncol. 2017 Feb;144(2):343-347. doi: 10.1016/j.ygyno.2016.11.032. Epub 2016 Dec 2.

PMID:
27919575
18.

Optimizing the treatment of ovarian cancer: Neoadjuvant chemotherapy and interval debulking versus primary debulking surgery for epithelial ovarian cancers likely to have suboptimal resection.

Gill SE, McGree ME, Weaver AL, Cliby WA, Langstraat CL.

Gynecol Oncol. 2017 Feb;144(2):266-273. doi: 10.1016/j.ygyno.2016.11.021. Epub 2016 Dec 1.

PMID:
27916269
19.

Abdominal Incision Injection of Liposomal Bupivacaine and Opioid Use After Laparotomy for Gynecologic Malignancies.

Kalogera E, Bakkum-Gamez JN, Weaver AL, Moriarty JP, Borah BJ, Langstraat CL, Jankowski CJ, Lovely JK, Cliby WA, Dowdy SC.

Obstet Gynecol. 2016 Nov;128(5):1009-1017.

PMID:
27741199
20.

Neoadjuvant chemotherapy for newly diagnosed, advanced ovarian cancer: Society of Gynecologic Oncology and American Society of Clinical Oncology Clinical Practice Guideline.

Wright AA, Bohlke K, Armstrong DK, Bookman MA, Cliby WA, Coleman RL, Dizon DS, Kash JJ, Meyer LA, Moore KN, Olawaiye AB, Oldham J, Salani R, Sparacio D, Tew WP, Vergote I, Edelson MI.

Gynecol Oncol. 2016 Oct;143(1):3-15. doi: 10.1016/j.ygyno.2016.05.022. Epub 2016 Aug 8.

Supplemental Content

Loading ...
Support Center